Takeda Pharmaceutical (TAK) Inventory (2018 - 2026)
Takeda Pharmaceutical has reported Inventory over the past 9 years, most recently at $8.9 billion for Q1 2026.
- For Q1 2026, Inventory rose 11.61% year-over-year to $8.9 billion; the TTM value through Mar 2026 reached $8.9 billion, up 11.61%, while the annual FY2026 figure was $9.3 billion, 16.1% up from the prior year.
- Inventory was $8.9 billion for Q1 2026 at Takeda Pharmaceutical, up from $8.0 billion in the prior quarter.
- Across five years, Inventory topped out at $8.9 billion in Q1 2026 and bottomed at $7.3 billion in Q1 2022.
- The 5-year median for Inventory is $8.0 billion (2025), against an average of $8.0 billion.
- Year-over-year, Inventory dropped 2.26% in 2025 and then rose 11.61% in 2026.
- Over 5 years, Inventory stood at $7.3 billion in 2022, then increased by 1.58% to $7.5 billion in 2023, then grew by 9.47% to $8.2 billion in 2024, then fell by 2.26% to $8.0 billion in 2025, then grew by 11.61% to $8.9 billion in 2026.
- The last three reported values for Inventory were $8.9 billion (Q1 2026), $8.0 billion (Q1 2025), and $8.2 billion (Q1 2024) per Business Quant data.